UBS Adjusts Price Target on Edwards Lifesciences to $78 From $75, Keeps Neutral Rating

瑞銀將愛德華生命科學的目標股價從75美元調整至78美元，保持中立評級

MT Newswires · 12/05 21:56 · 評級/大行評級

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.